These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Exploration of N-arylpiperazine Binding Sites of D2 Dopaminergic Receptor. Soskic V; Sukalovic V; Kostic-Rajacic S Mini Rev Med Chem; 2015; 15(12):988-1001. PubMed ID: 25723457 [TBL] [Abstract][Full Text] [Related]
8. 1-cinnamyl-4-(2-methoxyphenyl)piperazines: synthesis, binding properties, and docking to dopamine (D(2)) and serotonin (5-HT(1A)) receptors. Penjisević J; Sukalović V; Andrić D; Kostić-Rajacić S; Soskić V; Roglić G Arch Pharm (Weinheim); 2007 Sep; 340(9):456-65. PubMed ID: 17763374 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationships of a new model of arylpiperazines. 5. Study of the physicochemical influence of the pharmacophore on 5-HT(1a)/alpha(1)-adrenergic receptor affinity: synthesis of a new derivative with mixed 5-HT(1a)/d(2) antagonist properties. López-Rodríguez ML; Morcillo MJ; Fernández E; Porras E; Orensanz L; Beneytez ME; Manzanares J; Fuentes JA J Med Chem; 2001 Jan; 44(2):186-97. PubMed ID: 11170628 [TBL] [Abstract][Full Text] [Related]
10. Molecular modeling of the dopamine D2 and serotonin 5-HT1A receptor binding modes of the enantiomers of 5-OMe-BPAT. Homan EJ; Wikström HV; Grol CJ Bioorg Med Chem; 1999 Sep; 7(9):1805-20. PubMed ID: 10530928 [TBL] [Abstract][Full Text] [Related]
11. The dopamine D2 receptor dimer and its interaction with homobivalent antagonists: homology modeling, docking and molecular dynamics. Kaczor AA; Jörg M; Capuano B J Mol Model; 2016 Sep; 22(9):203. PubMed ID: 27491852 [TBL] [Abstract][Full Text] [Related]
12. New arylpiperazine derivatives with high affinity for alpha1A, D2 and 5-HT2A receptors. González-Gómez JC; Santana L; Uriarte E; Brea J; Villazón M; Loza MI; De Luca M; Rivas ME; Montenegro GY; Fontenla JA Bioorg Med Chem Lett; 2003 Jan; 13(2):175-8. PubMed ID: 12482418 [TBL] [Abstract][Full Text] [Related]
14. Electrostatic surface potential calculation on several new halogenated benzimidazole-like dopaminergic ligands. Sukalović V; Andrić D; Roglić G; Kostić-Rajaccić S; Soskić V Arch Pharm (Weinheim); 2004 Jul; 337(7):376-82. PubMed ID: 15237387 [TBL] [Abstract][Full Text] [Related]
15. 5-HT1A-versus D2-receptor selectivity of flesinoxan and analogous N4-substituted N1-arylpiperazines. Kuipers W; Kruse CG; van Wijngaarden I; Standaar PJ; Tulp MT; Veldman N; Spek AL; IJzerman AP J Med Chem; 1997 Jan; 40(3):300-12. PubMed ID: 9022796 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationships of new arylpiperazines: para substitution with electron-withdrawing groups decrease binding to 5-HT(1A) and D(2A) receptors. Santana L; Uriarte E; Fall Y; Teijeira M; Terán C; García-Martínez E; Tolf BR Eur J Med Chem; 2002 Jun; 37(6):503-10. PubMed ID: 12204476 [TBL] [Abstract][Full Text] [Related]
17. Certain 1,4-disubstituted aromatic piperidines and piperazines with extreme selectivity for the dopamine D4 receptor interact with a common receptor microdomain. Kortagere S; Gmeiner P; Weinstein H; Schetz JA Mol Pharmacol; 2004 Dec; 66(6):1491-9. PubMed ID: 15448188 [TBL] [Abstract][Full Text] [Related]
18. Enhanced D1 affinity in a series of piperazine ring substituted 1-piperazino-3-arylindans with potential atypical antipsychotic activity. Bøgesø KP; Arnt J; Frederiksen K; Hansen HO; Hyttel J; Pedersen H J Med Chem; 1995 Oct; 38(22):4380-92. PubMed ID: 7473566 [TBL] [Abstract][Full Text] [Related]
19. The Effect of Carboxamide/Sulfonamide Replacement in Arylpiperazinylalkyl Derivatives on Activity to Serotonin and Dopamine Receptors. Kowalski P; Śliwa P; Satała G; Kurczab R; Bartos I; Zuchowicz K Arch Pharm (Weinheim); 2017 Oct; 350(10):. PubMed ID: 28846141 [TBL] [Abstract][Full Text] [Related]